Literature DB >> 27562060

Aberrant fecal flora observed in guinea pigs with pressure overload is mitigated in animals receiving vagus nerve stimulation therapy.

Regenia B Phillips Campbell1, Michelle M Duffourc1, Robert V Schoborg1, Yanji Xu2, Xinyi Liu2, Bruce H KenKnight3, Eric Beaumont4.   

Abstract

Altered gut microbial diversity has been associated with several chronic disease states, including heart failure. Stimulation of the vagus nerve, which innervates the heart and abdominal organs, is proving to be an effective therapeutic in heart failure. We hypothesized that cervical vagus nerve stimulation (VNS) could alter fecal flora and prevent aberrations observed in fecal samples from heart failure animals. To determine whether microbial abundances were altered by pressure overload (PO), leading to heart failure and VNS therapy, a VNS pulse generator was implanted with a stimulus lead on either the left or right vagus nerve before creation of PO by aortic constriction. Animals received intermittent, open-loop stimulation or sham treatment, and their heart function was monitored by echocardiography. Left ventricular end-systolic and diastolic volumes, as well as cardiac output, were impaired in PO animals compared with baseline. VNS mitigated these effects. Metagenetic analysis was then performed using 16S rRNA sequencing to identify bacterial genera present in fecal samples. The abundance of 10 genera was significantly altered by PO, 8 of which were mitigated in animals receiving either left- or right-sided VNS. Metatranscriptomics analyses indicate that the abundance of genera that express genes associated with ATP-binding cassette transport and amino sugar/nitrogen metabolism was significantly changed following PO. These gut flora changes were not observed in PO animals subjected to VNS. These data suggest that VNS prevents aberrant gut flora following PO, which could contribute to its beneficial effects in heart failure patients.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  gut microbial diversity; pressure overload; vagus nerve stimulation

Mesh:

Year:  2016        PMID: 27562060     DOI: 10.1152/ajpgi.00218.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  5 in total

Review 1.  Targeting the Microbiome in Heart Failure.

Authors:  Allyson Zabell; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

2.  Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations.

Authors:  Martina E Spehlmann; Ashraf Y Rangrez; Dhiraj P Dhotre; Nesrin Schmiedel; Nikita Chavan; Corinna Bang; Oliver J Müller; Yogesh S Shouche; Andre Franke; Derk Frank; Norbert Frey
Journal:  Biomedicines       Date:  2022-03-30

Review 3.  Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure.

Authors:  Takehiro Kamo; Hiroshi Akazawa; Jun-Ichi Suzuki; Issei Komuro
Journal:  Korean Circ J       Date:  2017-08-23       Impact factor: 3.243

Review 4.  The role of intestinal microbiota in cardiovascular disease.

Authors:  Mengchao Jin; Zhiyuan Qian; Jiayu Yin; Weiting Xu; Xiang Zhou
Journal:  J Cell Mol Med       Date:  2019-02-03       Impact factor: 5.310

Review 5.  Analyzing the Complicated Connection Between Intestinal Microbiota and Cardiovascular Diseases.

Authors:  Tanishq Kumar; Rajoshee R Dutta; Vivek R Velagala; Benumadhab Ghosh; Abhay Mudey
Journal:  Cureus       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.